Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chau-Ting Yeh

Showing results (1-10 of 294) with videos related to

Pageof 30
Sort By:
Antiviral Therapy|June 3, 2010
Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapyChau-Ting Yeh
Future Microbiology|March 5, 2009
Is the NV-F agent a novel hepatitis virus?Chau-Ting Yeh
Journal of Hepatology|June 12, 2012
Eliminating hepatitis B virus through neonatal vaccination: can we make it?Chau-Ting Yeh, Ming-Wei Lai
Chang Gung Medical Journal|August 26, 2003
Primary biliary cirrhosis in antimitochondrial antibody-negative patients: Chang Gung Memorial Hospital experienceYung-Kuan Tsou, Chau-Ting Yeh
Antiviral Therapy|December 3, 2008
The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutantMing-Wei Lai, Chau-Ting Yeh
Hepatobiliary Surgery and Nutrition|July 15, 2014
OPN sesameKung-Hao Liang, Chau-Ting Yeh
Anticancer Research|February 28, 2023
Anticancer Effects of Antidepressants in Hepatocellular Carcinoma CellsYa-Hui Huang, Chau-Ting Yeh
Hepatology (Baltimore, Md.)|April 20, 2011
Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapyChao-Wei Hsu, Chau-Ting Yeh
Journal of Medical Virology|April 16, 2015
Detection of serum anti-NV-F antibodies in the convalescent phase of severe hepatitis in patients positive for tissue NV-F antigen and novel virus-like particlesChau-Ting Yeh, Mei-Lin Tsao
BMC Genomics|May 14, 2013
A gene expression restriction network mediated by sense and antisense Alu sequences located on protein-coding messenger RNAsKung-Hao Liang, Chau-Ting Yeh
Pageof 30

Showing results (1-10 of 294) with videos related to

Sort By:
Pageof 30
Antiviral Therapy|June 3, 2010
Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapyChau-Ting Yeh
Future Microbiology|March 5, 2009
Is the NV-F agent a novel hepatitis virus?Chau-Ting Yeh
Journal of Hepatology|June 12, 2012
Eliminating hepatitis B virus through neonatal vaccination: can we make it?Chau-Ting Yeh, Ming-Wei Lai
Chang Gung Medical Journal|August 26, 2003
Primary biliary cirrhosis in antimitochondrial antibody-negative patients: Chang Gung Memorial Hospital experienceYung-Kuan Tsou, Chau-Ting Yeh
Antiviral Therapy|December 3, 2008
The oncogenic potential of hepatitis B virus rtA181T/ surface truncation mutantMing-Wei Lai, Chau-Ting Yeh
Hepatobiliary Surgery and Nutrition|July 15, 2014
OPN sesameKung-Hao Liang, Chau-Ting Yeh
Anticancer Research|February 28, 2023
Anticancer Effects of Antidepressants in Hepatocellular Carcinoma CellsYa-Hui Huang, Chau-Ting Yeh
Hepatology (Baltimore, Md.)|April 20, 2011
Emergence of hepatitis B virus S gene mutants in patients experiencing hepatitis B surface antigen seroconversion after peginterferon therapyChao-Wei Hsu, Chau-Ting Yeh
Journal of Medical Virology|April 16, 2015
Detection of serum anti-NV-F antibodies in the convalescent phase of severe hepatitis in patients positive for tissue NV-F antigen and novel virus-like particlesChau-Ting Yeh, Mei-Lin Tsao
BMC Genomics|May 14, 2013
A gene expression restriction network mediated by sense and antisense Alu sequences located on protein-coding messenger RNAsKung-Hao Liang, Chau-Ting Yeh
Pageof 30